CDT Equity flags late filing of quarterly 10-Q report after Nasdaq notice

Conduit Pharmaceuticals

Conduit Pharmaceuticals

CDT

0.00
  • CDT Equity received a Nasdaq deficiency notice for failing to file its Form 10-Q for the quarter ended March 31, 2026 on time.
  • Nasdaq cited Listing Rule 5250(c)(1); the notice does not immediately affect listing or trading on the Nasdaq Capital Market.
  • A compliance plan is due by July 20, 2026; management expects to file the 10-Q once its review process is completed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605281615PRIMZONEFULLFEED9728287) on May 28, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.